MANCINI, ILARIA
MANCINI, ILARIA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Evaluation of different platelet-dependent von Willebrand factor activity assays to assess the in vivo inhibitory effect of caplacizumab on the von Willebrand factor–platelet interaction
2025 P. Colpani, L. Baronciani, I. Mancini, C. Novembrino, A. Lecchi, G. Cozzi, P. De Leo, M.B. Anzoletti, S. La Marca, M. Boscarino, M.T. Pagliari, A. Artoni, F. Peyvandi
Therapeutic plasma exchange-related complications in patients with immune-mediated thrombotic thrombocytopenic purpura: Complications of therapeutic plasma-exchange
2025 P. Agosti, I. Mancini, A. Artoni, C. Cardone, P. De Leo, C. Bichard, A. Truma, B. Ferrari, J.A. Giannotta, N.N. Fantini, M.C. Mocellin, D. Prati, F. Peyvandi
Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project)
2025 P. Coppo, M. Bubenheim, Y. Benhamou, L. Völker, P. Brinkkötter, L. Kühne, P. Knöbl, M.E. Mingot-Castellano, C. Pascual-Izquierdo, J. De La Rubia, J. Del Rio Garma, S. Chaturvedi, C. Masias, M. Mazepa, X.L. Zheng, G. Sinkovits, M. Réti, C.J. Patriquin, K. Pavenski, T. Boechat, J. Farias, E.F. Oliveira Ribeiro, M.L. Lobo De Andrade, A. Veyradier, B. Joly, R. Bouzid, K. Sakai, M. Matsumoto, P. Agosti, I. Mancini, F. Peyvandi, E. Gavriilaki, M. Stubbs, A. Hmaid, S. Cataland, B. Lämmle, M. Scully
Bortezomib for rituximab-refractory immune-mediated thrombotic thrombocytopenic purpura in the caplacizumab era: an Italian multicenter study
2025 J.A. Giannotta, A. Artoni, I. Mancini, P. Agosti, M. Carpenedo, A. Truma, S. Miri, B. Ferrari, P. De Leo, P. Salutari, G. Mancini, A. Molteni, E. Rinaldi, M. Bocchia, M. Napolitano, L. Prezioso, A. Cuccaro, E. Scarpa, A. Condorelli, D. Grimaldi, M. Massaia, F. Peyvandi
Efficacy and safety of azathioprine during remission of immune-mediated thrombotic thrombocytopenic purpura
2022 C. Bichard, I. Mancini, P. Agosti, M. Capecchi, P. De Leo, S. Arcudi, B. Ferrari, S.M. Trisolini, F. Longu, C. Fozza, A. Artoni, F. Peyvandi
Lombardy diagnostic and therapeutic network of thrombotic microangiopathy
2022 I. Mancini, P. Agosti, M. Boscarino, B. Ferrari, A. Artoni, R. Palla, M. Spreafico, G. Crovetti, E. Volpato, S. Rossini, C. Novelli, S. Gattillo, L. Barcella, M. Salmoiraghi, A. Falanga, F. Peyvandi, L. Russo, L. Barcella, E. Capuzzo, M. D'Agostino, P. Moreno, I. Alessandro, P. Ambrogio
ADAMTS13 activity, high VWF and FVIII levels in the pathogenesis of deep vein thrombosis
2021 M.T. Pagliari, M. Boscarino, A. Cairo, I. Mancini, I. Martinelli, P. Bucciarelli, F. Rossi, F.R. Rosendaal, F. Peyvandi
Role of ADAMTS13, VWF and F8 genes in deep vein thrombosis
2021 M.T. Pagliari, A. Cairo, M. Boscarino, I. Mancini, E. Pappalardo, P. Bucciarelli, I. Martinelli, F.R. Rosendaal, F. Peyvandi
Efficacy and Safety of Azathioprine during Remission of Immune-Mediated Thrombotic Thrombocytopenic Purpura
2021 C. Bichard, I. Mancini, P. Agosti, P. De Leo, A. Artoni, M. Capecchi, S.M. Trisolini, C. Fozza, F. Peyvandi
Pro-coagulant imbalance in patients with community acquired pneumonia assessed on admission and one month after hospital discharge
2021 A. Tripodi, S.C. Rossi, M. Clerici, G. Merati, E. Scalambrino, I. Mancini, L. Baronciani, M. Boscarino, V. Monzani, F. Peyvandi
Factor V Leiden but Not Factor II 20210G>A Is a Risk Factor in a Large Cohort of Iranian Patients with Premature Coronary Artery Disease
2020 I. Mancini, S. Sadeghian, M.T. Pagliari, S.H. Abbasi, H. Poorhosseini, M.A. Boroumand, M. Lotfi-Tokaldany, E. Pappalardo, G. Colombo, F. Tafuri, P. Agosti, F.R. Rosendaal, F. Peyvandi
Prevalence of the age-related diseases in older patients with acquired thrombotic thrombocytopenic purpura
2020 P. Agosti, I. Mancini, F. Gianniello, P. Bucciarelli, A. Artoni, B. Ferrari, S. Pontiggia, S.M. Trisolini, L. Facchini, C. Carbone, F. Peyvandi
The ADAMTS13-von Willebrand factor axis in COVID-19 patients
2020 I. Mancini, L. Baronciani, A. Artoni, P. Colpani, M. Biganzoli, G. Cozzi, C. Novembrino, M. Boscolo Anzoletti, V. De Zan, M.T. Pagliari, R. Gualtierotti, S. Aliberti, M. Panigada, G. Grasselli, F. Blasi, F. Peyvandi
Lombardy network for the study and treatment of patients undergoing apheresis
2020 I. Mancini, P. Agosti, M. Boscarino, B. Ferrari, A. Artoni, R. Palla, L. Barcella, A. Falanga, F. Peyvandi
Factor V Leiden but not factor II 20210G>A is a risk factor in a large cohort of Iranian patients with premature coronary artery disease
2020 I. Mancini, S. Sadeghian, M.T. Pagliari, S.H. Abbasi, H. Poorhosseini, M.A. Boroumand, M. Lotfi-tokaldany, E. Pappalardo, G. Colombo, F. Tafuri, P. Agosti, F.R. Rosendaal, F. Peyvandi
Dramatic presentation of acquired thrombotic thrombocytopenic purpura associated with COVID-19
2020 M. Capecchi, C. Mocellin, C. Abbruzzese, I. Mancini, D. Prati, F. Peyvandi
The features of acquired thrombotic thrombocytopenic purpura occurring at advanced age
2020 P. Agosti, I. Mancini, A. Artoni, B. Ferrari, S. Pontiggia, S.M. Trisolin, L. Facchini, F. Peyvandi
The HLA Variant rs6903608 Is Associated with Disease Onset and Relapse of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Caucasians
2020 I. Mancini, E. Giacomini, S. Pontiggia, A. Artoni, B. Ferrari, E. Pappalardo, R. Gualtierotti, S.M. Trisolini, S. Capria, L. Facchini, K. Codeluppi, E. Rinaldi, D. Pastore, S. Campus, C. Caria, A. Caddori, D. Nicolosi, G. Giuffrida, V. Agostini, U. Roncarati, C. Mannarella, A. Fragasso, G.M. Podda, S. Birocchi, A.M. Cerbone, A. Tufano, G. Menna, M. Pizzuti, M. Ronchi, A. De Fanti, S. Amarri, M. Defina, M. Bocchia, S. Cerù, S. Gattillo, F.R. Rosendaal, F. Peyvandi
Lombardy Network for the Study and Treatment of Patients Undergoing Apheresis
2020 I. Mancini, P. Agosti, M. Boscarino, B. Ferrari, A. Artoni, R. Palla, L. Barcella, A. Falanga, F. Peyvandi
Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura
2020 S. Riva, I. Mancini, A. Maino, B. Ferrari, A. Artoni, P. Agosti, F. Peyvandi